James Chalmers

3 weeks ago | ajmc.com | Julia Bonavitacola |Pearl Steinzor |James Chalmers

James Chalmers, MD, chair of respiratory research, Cardiology, at the University of Dundee, Scotland, discussed how brensocatib would alter the way that clinicians treat bronchiectasis should it be approved for general use. This transcript has been lightly edited for clarity; captions are auto-generated. TranscriptHow would the approval of brensocatib change the landscape of bronchiectasis? If approved, this would be the first licensed treatment for bronchiectasis.

4 weeks ago | ajmc.com | Julia Bonavitacola |Pearl Steinzor |James Chalmers

James Chalmer, MD, chair of Respiratory Research, Cardiology, at the University of Dundee, Scotland, spoke at the American Thoracic Society 2025 International Conference about how different dosages of brensocatib (Insmed Incorporated) proved effective in people living with bronchiectasis, with specific positive results based on which dose the patient took. This transcript has been lightly edited for clarity; captions were auto-generated.

1 month ago | ajmc.com | Julia Bonavitacola |Pearl Steinzor |James Chalmers

James Chalmers, MD, chair of respiratory research, Cardiology, at the University of Dundee, Scotland, discussed the ways that bronchiectasis could present itself as well as how brensocatib aims to address the underlying causes of exacerbations in the condition. This transcript has been lightly edited for clarity; captions are auto-generated. TranscriptWhat is bronchiectasis and how can the condition be treated? Bronchiectasis is a chronic respiratory disease. It's common.

Dec 5, 2024 | publicaccountant.com.au | James Chalmers

Almost two years on from news of the PwC scandal breaking, how close is the profession to rebuilding trust? At a glance IPA urges profession proactivity in leading ongoing reforms from PwC scandal. The UK’s Financial Reporting Council offered as a model of how industry-led regulation could work in harmony with governmental oversight. Protecting the term “accountant” a crucial way to protect the public and improve the profession’s respect.

Dec 4, 2024 | resmedjournal.com | UCL Respiratory |Michael Tunney |Zina Alfahl |Gisli G Einarsson |J. Stuart Elborn |Deirdre F Gilpin | +10 more

KeywordsBronchiectasismicrobiome compositionquantitative real time PCRbacterial densityclinical outcomesquality of lifeGet full text accessLog in, subscribe or purchase for full access. REFERENCES1. O’Donnell, A.E.Bronchiectasis updateCurrent Opinion in Infectious Diseases. 2018; 312. Chandrasekaran, R. ∙ Mac Aogáin, M. ∙ Chalmers, J.D. ... Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasisBMC Pulmonary Medicine. 2018; 18:833. Chalmers, J.D. ∙ Polverino, E.